These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8302065)
21. Long-term pulmonary function after living-donor lobar lung transplantation in adults. Bowdish ME; Pessotto R; Barbers RG; Schenkel FA; Starnes VA; Barr ML Ann Thorac Surg; 2005 Feb; 79(2):418-25. PubMed ID: 15680807 [TBL] [Abstract][Full Text] [Related]
22. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis. Faro A; Shepherd R; Huddleston CB; Lowell J; Gandhi S; Nadler M; Sweet SC Transplantation; 2007 Jun; 83(11):1435-9. PubMed ID: 17565316 [TBL] [Abstract][Full Text] [Related]
23. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. De Perrot M; Waddell TK; Shargall Y; Pierre AF; Fadel E; Uy K; Chaparro C; Hutcheon M; Singer LG; Keshavjee S J Thorac Cardiovasc Surg; 2007 Feb; 133(2):525-31. PubMed ID: 17258592 [TBL] [Abstract][Full Text] [Related]
25. Lung transplant outcomes in white and African American recipients: special focus on acute and chronic rejection. Lingaraju R; Pochettino A; Blumenthal NP; Mendez J; Lee J; Christie JD; Kotloff RM; Ahya VN; Hadjiliadis D J Heart Lung Transplant; 2009 Jan; 28(1):8-13. PubMed ID: 19134524 [TBL] [Abstract][Full Text] [Related]
26. Lung transplantation: a decade of experience. Meyers BF; Lynch J; Trulock EP; Guthrie TJ; Cooper JD; Patterson GA Ann Surg; 1999 Sep; 230(3):362-70; discussion 370-1. PubMed ID: 10493483 [TBL] [Abstract][Full Text] [Related]
27. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858 [TBL] [Abstract][Full Text] [Related]
28. Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival. de Perrot M; Chaparro C; McRae K; Waddell TK; Hadjiliadis D; Singer LG; Pierre AF; Hutcheon M; Keshavjee S J Thorac Cardiovasc Surg; 2004 May; 127(5):1493-501. PubMed ID: 15116013 [TBL] [Abstract][Full Text] [Related]
29. Lung and heart-lung transplantation at University of Pittsburgh: 1982-2009. Thacker J; Toyoda Y Clin Transpl; 2009; ():179-95. PubMed ID: 20524284 [TBL] [Abstract][Full Text] [Related]
30. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388 [TBL] [Abstract][Full Text] [Related]
31. Survival and functional outcome after single and bilateral lung transplantation. Loyola Lung Transplant Team. Montoya A; Mawulawde K; Houck J; Sullivan H; Lonchyna V; Blakeman B; Hinkamp T; Garrity E; Pifarre R Surgery; 1994 Oct; 116(4):712-8. PubMed ID: 7940170 [TBL] [Abstract][Full Text] [Related]
32. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience. Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967 [TBL] [Abstract][Full Text] [Related]
34. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. Bando K; Paradis IL; Similo S; Konishi H; Komatsu K; Zullo TG; Yousem SA; Close JM; Zeevi A; Duquesnoy RJ J Thorac Cardiovasc Surg; 1995 Jul; 110(1):4-13; discussion 13-4. PubMed ID: 7609567 [TBL] [Abstract][Full Text] [Related]
35. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for the development of obliterative bronchiolitis after lung transplantation. Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205 [TBL] [Abstract][Full Text] [Related]
37. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. Kshettry VR; Kroshus TJ; Savik K; Hertz MI; Bolman RM Chest; 1996 Sep; 110(3):704-9. PubMed ID: 8797415 [TBL] [Abstract][Full Text] [Related]
38. Impact of bilateral versus single lung transplantation on survival in recipients 60 years of age and older: analysis of United Network for Organ Sharing database. Nwakanma LU; Simpkins CE; Williams JA; Chang DC; Borja MC; Conte JV; Shah AS J Thorac Cardiovasc Surg; 2007 Feb; 133(2):541-7. PubMed ID: 17258596 [TBL] [Abstract][Full Text] [Related]
39. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients. Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986 [TBL] [Abstract][Full Text] [Related]
40. Outcome of lung transplantation in elderly recipients. Tomaszek SC; Fibla JJ; Dierkhising RA; Scott JP; Shen KR; Wigle DA; Cassivi SD Eur J Cardiothorac Surg; 2011 May; 39(5):726-31. PubMed ID: 21084198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]